高压氧治疗在即刻组织扩张器乳房再造中的应用
回顾性分析6年间348例(552侧)即刻组织扩张器乳房再造患者,其中299例(477侧)为胸肌前放置,49例(75侧)为胸肌后放置;仅胸肌前患者接受高压氧治疗(19例/33侧 vs 0例/0侧,P=0.037)。接受高压氧治疗的乳房在30天和90天随访中乳房切除皮瓣坏死、因坏死切除重返手术室及扩张器取出率均更高,但在乳房切除皮瓣坏死者中高压氧显著挽救更多乳房切除腔(76% vs 41%,P<0.0001)。
要点
- 胸肌前放置组织扩张器患者接受高压氧治疗的比例显著高于胸肌后放置者(19例/33侧 vs 0例/0侧,P=0.037)。
- 接受高压氧治疗的乳房30天乳房切除皮瓣坏死率73% vs 5.6%(P<0.001),90天76% vs 6.5%(P<0.001)。
- 在发生乳房切除皮瓣坏死者中,高压氧挽救乳房切除腔的比例为76% vs 41%(P<0.0001)。
核心结论
- 胸肌前放置组织扩张器的患者显著更可能接受高压氧治疗。
- 与未治疗相比,高压氧能挽救几乎两倍的乳房切除腔,为乳房切除皮瓣缺血的治疗选择提供了有价值的信息。
研究设计与样本
- 回顾性综述,纳入6年期间接受即刻组织扩张器乳房再造的患者,收集人口学、术中数据、高压氧治疗、并发症及最终乳房再造类型,按患者和按乳房进行分析。
- 共348例患者(552侧乳房),其中299例(86%)患者(477侧乳房)为胸肌前放置,49例(14%)患者(75侧乳房)为胸肌后放置。
主要发现
- 仅胸肌前患者接受高压氧治疗(19例/33侧 vs 0例/0侧,P=0.037)。
- 接受高压氧治疗的乳房30天乳房切除皮瓣坏死率73% vs 5.6%(P<0.001),90天76% vs 6.5%(P<0.001)。
- 接受高压氧治疗的乳房30天因坏死切除重返手术室率18% vs 3.2%(P=0.001),90天21% vs 5.4%(P=0.003)。
- 接受高压氧治疗的乳房30天扩张器取出率21% vs 1.8%(P<0.001),90天24% vs 3.8%(P<0.00001)。
- 上述率从30天至90天无显著增加;在发生乳房切除皮瓣坏死者中,高压氧挽救乳房切除腔76% vs 41%(P<0.0001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prepectoral tissue expander (TE) placement is an increasingly used breast reconstruction technique but may have a higher risk for mastectomy skin flap ischemia compared to subpectoral TE placement. Hyperbaric oxygen therapy (HBOT) has been shown to salvage compromised mastectomy skin flaps, but there is limited evidence on which patients require HBOT and benefit most from this treatment. METHODS: We retrospectively reviewed patients undergoing immediate TE breast reconstruction over a 6-year period. Patient demographics, intraoperative data, HBOT treatment, complications, and final breast reconstruction type were collected. Analyses were performed by patient and by breast. RESULTS: Among 348 patients (552 breasts), 299 (86%) patients (477 breasts) had prepectoral and 49 (14%) patients (75 breasts) had subpectoral TE placement. Only prepectoral patients received HBOT (19 patients/33 breasts vs 0 patients/breasts, P = 0.037). Breasts receiving HBOT had higher rates of mastectomy skin necrosis (30-day: 73% vs 5.6%, P < 0.001; 90-day: 76% vs 6.5%, P < 0.001), returns to the OR for necrosis excision (30-day: 18% vs 3.2%, P = 0.001; 90-day: 21% vs 5.4%, P = 0.003), and TE explantation (30-day: 21% vs 1.8%, P < 0.001; 90-day: 24% vs 3.8%, P < 0.00001) at the 30- and 90-day postoperative periods. However, these rates did not significantly increase from 30 to 90 days. For those with mastectomy skin necrosis, HBOT salvaged significantly more mastectomy pockets (76% vs 41%, P < 0.0001). CONCLUSIONS: Patients with prepectoral TE placement were significantly more likely to receive HBOT. Compared to no treatment, HBOT was able to salvage almost twice as many mastectomy pockets, providing valuable information for mastectomy skin flap ischemia treatment options.
引用
- Zhu KJ, Heron MJ, Tiongco RFP, et al. Hyperbaric Oxygen Therapy in Immediate Tissue Expander-Based Breast Reconstruction. Ann Plast Surg. 2025. PMID: 40167090. doi:10.1097/SAP.0000000000004321
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。